All stock lists
PepGen Inc. (NASDAQ:PEPG)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
5.48+3.09 (+129.28%)
Market cap
$379M
Insider Score
Health Score
Analyst consensus
Listed since
May 6, 2022
Website
Insider Score
––Not scored
PEPG Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
PEPG analyst forecast
PEPG analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
PEPG 12-month price target
No published price targets in the last 12 months.
PEPG ratings mix, last 12 months
Buy Hold Sell
Best analysts covering PEPG
- Guggenheim100%success rate · +0.8% avg return · 1 call
- HC Wainwright & Co.42%success rate · +21.1% avg return · 12 calls
- Wedbush20%success rate · -40.6% avg return · 10 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PEPG analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-09-09 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-05-13 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-04-01 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-03-31 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-02-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-11-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-10-27 |
| — | Wedbush | Outperform | — | — | Reiterated | 2025-09-30 |
| — | Stifel | Buy | — | — | Reiterated | 2025-09-25 |
| — | Wedbush | Outperform | — | — | Reiterated | 2025-09-25 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-09-25 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-09-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-05-29 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-05-09 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-02-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-30 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2024-12-16 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2024-11-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-08 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-11-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-01 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-07-31 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-15 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-05-15 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-03-07 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-01-30 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-09-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-09 |
| — | Wedbush | Outperform | — | — | Reiterated | 2023-06-14 |
| — | Stifel | Buy | — | — | Reiterated | 2023-06-14 |
| — | Wedbush | Outperform | — | — | Reiterated | 2023-05-31 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-12 |
| — | Wedbush | Outperform | — | — | Reiterated | 2023-03-24 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-11-10 |
PEPG earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-12 | -0.63 | -0.52 | $0 | $0 |
| 2026-03-04 | -0.40 | -0.27 | $0 | $0 |
| 2026-05-12 | -0.31 | -0.26 | $0 | $0 |
| 2026-08-06 | -0.28 | -0.26 | $0 | $0 |
| 2026-11-11Upcoming | -0.27 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.